BeStock  
Markets › Compare › KURA vs CGEM

KURA vs CGEM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
KURA · Kura Oncology$10.67 ▲ 1.33%
CGEM · Cullinan Therapeutics$15.63 ▼ 3.82%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

57128199270341Oct 9, '25Apr 9, '26Oct 7, '26
  • KURA +4.1%
  • CGEM +121.7%

Head to head

MetricKURACGEM
Price$10.67$15.63
Change today▲ 1.33%▼ 3.82%
Market cap$949.21M$1.01B
Return, 3 months-11.7%-15.0%
Return, year to date+2.7%+51.0%
Return, 1 year+5.9%+142.3%
P/E (TTM)-3.2-5.0
P/B19.63.1
P/E percentile vs own 5y85th33rd
Dividend yield––
Revenue growth (YoY, latest qtr)+36.5%–
Net profit growth (YoY)-3.3%+23.3%
Gross margin99.3%–
Operating margin-411.9%–
Net margin-384.3%–
Return on equity-167.7%-50.3%
Analyst target vs. price+166.5%+126.0%
Analyst buy share100%100%
RSI (14)4136
30-day volatility38.1%85.4%
Max drawdown, 1 year-39.0%-36.7%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CGEM is the largest of the group by market value.
  • CGEM has returned the most over the past year.
  • CGEM carries the lowest trailing P/E.
  • KURA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top